Multiple sclerosis (MS) is an immunological disease that causes acute inflammatory lesions
and chronic inflammation in the CNS, leading to tissue damage and disability. As awareness …

Background The incidence of multiple sclerosis (MS) has reportedly increased over time;
however, change in MS incidence has not been rigorously assessed globally. Methods We …

Background: Multiple sclerosis (MS) is a complex disease with new drugs becoming
available in the past years. There is a need for a reference tool compiling current data to aid …

Objective To describe the pattern of development of incidence of multiple sclerosis (MS)
over 60 years in Denmark with age-period-cohort analyses and seasonality of birth. Methods …

Multiple sclerosis (MS) is the most common acquired demyelinating disorder of the central
nervous system (CNS). Diagnosing MS can be very challenging owing to its variable clinical …

Over the past several decades, significant advances have been made in identifying factors
that contribute to the pathogenesis of multiple sclerosis (MS) and have culminated in the …

Age and the risks of high-efficacy disease modifying drugs i... : Current Opinion in
Neurology Age and the risks of high-efficacy disease modifying drugs in multiple sclerosis …

Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous system. An
increase in MS incidence over time is reported in several regions of the world. We aimed to …

Multiple sclerosis is a chronic, inflammatory, and neurodegenerative disease of the central
nervous system and a major cause of neurological disability in young adults. Its prevalence …

Psychiatric disorders frequently occur in patients with multiple sclerosis (MS); however,
limited reports are available on these comorbidities. We aimed to investigate the …